Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents Jose Luis Jimenez Moro, Mourad Tighiouart, Mauro Gasparini (2019) Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents, In: BIOMETRICAL JOURNAL, ISSN: 0323-3847